Towards the development of improved thrombolytic agents.
Lijnen
H R
HR
Center for Thrombosis and Vascular Research, K.U.L., Campus Gasthuisberg, Leuven, Belgium.
Collen
D
D
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010960:Plasminogen Activators / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator